TrialBreast cancer research and treatment2020

Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence.

Tommy A Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.